Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16092 entries
Sorted by: Best Match Show Resources per page
Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?.

Journal of clinical medicine

De Vecchis R, Cantatrione C, Mazzei D, Baldi C.
PMID: 27706088
J Clin Med. 2016 Oct 02;5(10). doi: 10.3390/jcm5100086.

In the congestive heart failure (CHF) setting, chronic hyponatremia is very common. The present review aims at addressing topics relevant to the pathophysiology of hyponatremia in the course of CHF as well as its optimal treatment, including the main...

Cite
De Vecchis R, Cantatrione C, Mazzei D, et al. Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. J Clin Med. 2016;5(10)doi: 10.3390/jcm5100086.
De Vecchis, R., Cantatrione, C., Mazzei, D., & Baldi, C. (2016). Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. Journal of clinical medicine, 5(10), . https://doi.org/10.3390/jcm5100086
De Vecchis, Renato, et al. "Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?." Journal of clinical medicine vol. 5,10 (2016). doi: https://doi.org/10.3390/jcm5100086
De Vecchis R, Cantatrione C, Mazzei D, Baldi C. Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?. J Clin Med. 2016 Oct 02;5(10). doi: 10.3390/jcm5100086. PMID: 27706088; PMCID: PMC5086588.
Copy Download .nbib Format: NLM
Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy.

Journal of clinical medicine research

Ayrian E, Kaye AD, Varner CL, Guerra C, Vadivelu N, Urman RD, Zelman V, Lumb PD, Rosa G, Bilotta F.
PMID: 26345202
J Clin Med Res. 2015 Oct;7(10):731-41. doi: 10.14740/jocmr2256w. Epub 2015 Aug 23.

Various clinical trials have assessed how intraoperative anesthetics can affect early recovery, hemodynamics and nociception after supratentorial craniotomy. Whether or not the difference in recovery pattern differs in a meaningful way with anesthetic choice is controversial. This review examines...

Cite
Ayrian E, Kaye AD, Varner CL, et al. Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy. J Clin Med Res. 2015;7(10):731-41doi: 10.14740/jocmr2256w.
Ayrian, E., Kaye, A. D., Varner, C. L., Guerra, C., Vadivelu, N., Urman, R. D., Zelman, V., Lumb, P. D., Rosa, G., & Bilotta, F. (2015). Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy. Journal of clinical medicine research, 7(10), 731-41. https://doi.org/10.14740/jocmr2256w
Ayrian, Eugenia, et al. "Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy." Journal of clinical medicine research vol. 7,10 (2015): 731-41. doi: https://doi.org/10.14740/jocmr2256w
Ayrian E, Kaye AD, Varner CL, Guerra C, Vadivelu N, Urman RD, Zelman V, Lumb PD, Rosa G, Bilotta F. Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy. J Clin Med Res. 2015 Oct;7(10):731-41. doi: 10.14740/jocmr2256w. Epub 2015 Aug 23. PMID: 26345202; PMCID: PMC4554211.
Copy Download .nbib Format: NLM
Assessment of Myocardial Performance Index and Aortic Elasticity in Patients With Beta-Thalassemia Major.

Journal of clinical medicine research

Sahin C, Basaran O, Altun I, Akin F, Topal Y, Topal H, Biteker M, Azik MF.
PMID: 26346439
J Clin Med Res. 2015 Oct;7(10):795-801. doi: 10.14740/jocmr2293w. Epub 2015 Aug 23.

BACKGROUND: This study aimed to assess myocardial performance index (MPI) and arterial elasticity indices in asymptomatic patients with beta-thalassemia major without known heart disease and to determine relationship between these indices and parameters indicating iron load of body.METHODS: The...

Cite
Sahin C, Basaran O, Altun I, et al. Assessment of Myocardial Performance Index and Aortic Elasticity in Patients With Beta-Thalassemia Major. J Clin Med Res. 2015;7(10):795-801doi: 10.14740/jocmr2293w.
Sahin, C., Basaran, O., Altun, I., Akin, F., Topal, Y., Topal, H., Biteker, M., & Azik, M. F. (2015). Assessment of Myocardial Performance Index and Aortic Elasticity in Patients With Beta-Thalassemia Major. Journal of clinical medicine research, 7(10), 795-801. https://doi.org/10.14740/jocmr2293w
Sahin, Cem, et al. "Assessment of Myocardial Performance Index and Aortic Elasticity in Patients With Beta-Thalassemia Major." Journal of clinical medicine research vol. 7,10 (2015): 795-801. doi: https://doi.org/10.14740/jocmr2293w
Sahin C, Basaran O, Altun I, Akin F, Topal Y, Topal H, Biteker M, Azik MF. Assessment of Myocardial Performance Index and Aortic Elasticity in Patients With Beta-Thalassemia Major. J Clin Med Res. 2015 Oct;7(10):795-801. doi: 10.14740/jocmr2293w. Epub 2015 Aug 23. PMID: 26346439; PMCID: PMC4554220.
Copy Download .nbib Format: NLM
Non-Proteinuric Diabetic Nephropathy.

Journal of clinical medicine

Robles NR, Villa J, Gallego RH.
PMID: 26371050
J Clin Med. 2015 Sep 07;4(9):1761-73. doi: 10.3390/jcm4091761.

Diabetic nephropathy patients traditionally show significant macroalbuminuria prior to the development of renal impairment. However, this clinical paradigm has recently been questioned. Epidemiological surveys confirm that chronic kidney disease (CKD) diagnosed by a low glomerular filtration rate (GFR) is...

Cite
Robles NR, Villa J, Gallego RH. Non-Proteinuric Diabetic Nephropathy. J Clin Med. 2015;4(9):1761-73doi: 10.3390/jcm4091761.
Robles, N. R., Villa, J., & Gallego, R. H. (2015). Non-Proteinuric Diabetic Nephropathy. Journal of clinical medicine, 4(9), 1761-73. https://doi.org/10.3390/jcm4091761
Robles, Nicolas Roberto, et al. "Non-Proteinuric Diabetic Nephropathy." Journal of clinical medicine vol. 4,9 (2015): 1761-73. doi: https://doi.org/10.3390/jcm4091761
Robles NR, Villa J, Gallego RH. Non-Proteinuric Diabetic Nephropathy. J Clin Med. 2015 Sep 07;4(9):1761-73. doi: 10.3390/jcm4091761. PMID: 26371050; PMCID: PMC4600158.
Copy Download .nbib Format: NLM
EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration.

Journal of clinical medicine

Yoshida S, Kato T, Kato Y.
PMID: 27058562
J Clin Med. 2016 Apr 06;5(4). doi: 10.3390/jcm5040043.

Epithelial-mesenchymal transition (EMT) and cell migration are important processes in embryonic development of many tissues as well as oncogenesis. The pituitary gland is a master endocrine tissue and recent studies indicate that Sox2-expressing stem/progenitor cells actively migrate and develop...

Cite
Yoshida S, Kato T, Kato Y. EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration. J Clin Med. 2016;5(4)doi: 10.3390/jcm5040043.
Yoshida, S., Kato, T., & Kato, Y. (2016). EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration. Journal of clinical medicine, 5(4), . https://doi.org/10.3390/jcm5040043
Yoshida, Saishu, et al. "EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration." Journal of clinical medicine vol. 5,4 (2016). doi: https://doi.org/10.3390/jcm5040043
Yoshida S, Kato T, Kato Y. EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and Regeneration. J Clin Med. 2016 Apr 06;5(4). doi: 10.3390/jcm5040043. PMID: 27058562; PMCID: PMC4850466.
Copy Download .nbib Format: NLM
Astaxanthin as a Potential Protector of Liver Function: A Review.

Journal of clinical medicine research

Chen JT, Kotani K.
PMID: 27635173
J Clin Med Res. 2016 Oct;8(10):701-4. doi: 10.14740/jocmr2672w. Epub 2016 Aug 30.

Protecting against liver damage, such as non-alcoholic fatty liver disease, is currently considered to be important for the prevention of adverse conditions, such as cardiovascular and cancerous diseases. Liver damage often occurs in relation to oxidative stress with metabolic...

Cite
Chen JT, Kotani K. Astaxanthin as a Potential Protector of Liver Function: A Review. J Clin Med Res. 2016;8(10):701-4doi: 10.14740/jocmr2672w.
Chen, J. T., & Kotani, K. (2016). Astaxanthin as a Potential Protector of Liver Function: A Review. Journal of clinical medicine research, 8(10), 701-4. https://doi.org/10.14740/jocmr2672w
Chen, Jui-Tung, and Kotani, Kazuhiko. "Astaxanthin as a Potential Protector of Liver Function: A Review." Journal of clinical medicine research vol. 8,10 (2016): 701-4. doi: https://doi.org/10.14740/jocmr2672w
Chen JT, Kotani K. Astaxanthin as a Potential Protector of Liver Function: A Review. J Clin Med Res. 2016 Oct;8(10):701-4. doi: 10.14740/jocmr2672w. Epub 2016 Aug 30. PMID: 27635173; PMCID: PMC5012237.
Copy Download .nbib Format: NLM
Change of Serum BNP Between Admission and Discharge After Acute Decompensated Heart Failure Is a Better Predictor of 6-Month All-Cause Mortality Than the Single BNP Value Determined at Admission.

Journal of clinical medicine research

De Vecchis R, Ariano C, Giandomenico G, Di Maio M, Baldi C.
PMID: 27635179
J Clin Med Res. 2016 Oct;8(10):737-42. doi: 10.14740/jocmr2691w. Epub 2016 Aug 30.

BACKGROUND: B-type natriuretic peptide (BNP) is regarded as a reliable predictor of outcome in patients with acute decompensated heart failure (ADHF). However, according to some scholars, a single isolated measurement of serum BNP at the time of hospital admission...

Cite
De Vecchis R, Ariano C, Giandomenico G, et al. Change of Serum BNP Between Admission and Discharge After Acute Decompensated Heart Failure Is a Better Predictor of 6-Month All-Cause Mortality Than the Single BNP Value Determined at Admission. J Clin Med Res. 2016;8(10):737-42doi: 10.14740/jocmr2691w.
De Vecchis, R., Ariano, C., Giandomenico, G., Di Maio, M., & Baldi, C. (2016). Change of Serum BNP Between Admission and Discharge After Acute Decompensated Heart Failure Is a Better Predictor of 6-Month All-Cause Mortality Than the Single BNP Value Determined at Admission. Journal of clinical medicine research, 8(10), 737-42. https://doi.org/10.14740/jocmr2691w
De Vecchis, Renato, et al. "Change of Serum BNP Between Admission and Discharge After Acute Decompensated Heart Failure Is a Better Predictor of 6-Month All-Cause Mortality Than the Single BNP Value Determined at Admission." Journal of clinical medicine research vol. 8,10 (2016): 737-42. doi: https://doi.org/10.14740/jocmr2691w
De Vecchis R, Ariano C, Giandomenico G, Di Maio M, Baldi C. Change of Serum BNP Between Admission and Discharge After Acute Decompensated Heart Failure Is a Better Predictor of 6-Month All-Cause Mortality Than the Single BNP Value Determined at Admission. J Clin Med Res. 2016 Oct;8(10):737-42. doi: 10.14740/jocmr2691w. Epub 2016 Aug 30. PMID: 27635179; PMCID: PMC5012243.
Copy Download .nbib Format: NLM
Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women: Foes Becoming Friends?.

Journal of clinical medicine research

Sinha SK, Khanra D, Jha MJ, Singh K, Razi M, Goel A, Mishra V, Asif M, Sachan M, Afdaali N, Kumar A, Thakur R, Krishna V, Pandey U, Varma CM.
PMID: 27635184
J Clin Med Res. 2016 Oct;8(10):760-3. doi: 10.14740/jocmr2674w. Epub 2016 Aug 30.

ALCAPA syndrome (anomalous origin of the left coronary artery from the pulmonary artery) is a rare disease but lethal with clinical expression from myocardial infarction, congestive heart failure to death during early infancy and unusual survival to adulthood. We...

Cite
Sinha SK, Khanra D, Jha MJ, et al. Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women: Foes Becoming Friends?. J Clin Med Res. 2016;8(10):760-3doi: 10.14740/jocmr2674w.
Sinha, S. K., Khanra, D., Jha, M. J., Singh, K., Razi, M., Goel, A., Mishra, V., Asif, M., Sachan, M., Afdaali, N., Kumar, A., Thakur, R., Krishna, V., Pandey, U., & Varma, C. M. (2016). Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women: Foes Becoming Friends?. Journal of clinical medicine research, 8(10), 760-3. https://doi.org/10.14740/jocmr2674w
Sinha, Santosh Kumar, et al. "Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women: Foes Becoming Friends?." Journal of clinical medicine research vol. 8,10 (2016): 760-3. doi: https://doi.org/10.14740/jocmr2674w
Sinha SK, Khanra D, Jha MJ, Singh K, Razi M, Goel A, Mishra V, Asif M, Sachan M, Afdaali N, Kumar A, Thakur R, Krishna V, Pandey U, Varma CM. Unusual Survival of Anomalous Left Coronary Artery From the Pulmonary Artery With Severe Rheumatic Mitral Stenosis in Septuagenarian Women: Foes Becoming Friends?. J Clin Med Res. 2016 Oct;8(10):760-3. doi: 10.14740/jocmr2674w. Epub 2016 Aug 30. PMID: 27635184; PMCID: PMC5012248.
Copy Download .nbib Format: NLM
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders.

Journal of clinical medicine

Castaman G, Linari S.
PMID: 28394285
J Clin Med. 2017 Apr 10;6(4). doi: 10.3390/jcm6040045.

Along with haemophilia A and B, von Willebrand disease (VWD) and rare bleeding disorders (RBDs) cover all inherited bleeding disorders of coagulation. Bleeding tendency, which can range from extremely severe to mild, is the common symptom. VWD, due to...

Cite
Castaman G, Linari S. Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med. 2017;6(4)doi: 10.3390/jcm6040045.
Castaman, G., & Linari, S. (2017). Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. Journal of clinical medicine, 6(4), . https://doi.org/10.3390/jcm6040045
Castaman, Giancarlo, and Linari, Silvia. "Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders." Journal of clinical medicine vol. 6,4 (2017). doi: https://doi.org/10.3390/jcm6040045
Castaman G, Linari S. Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med. 2017 Apr 10;6(4). doi: 10.3390/jcm6040045. PMID: 28394285; PMCID: PMC5406777.
Copy Download .nbib Format: NLM
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation.

Journal of clinical medicine

Kagiya T.
PMID: 26343739
J Clin Med. 2015 Aug 28;4(9):1741-52. doi: 10.3390/jcm4091741.

Osteolytic bone metastasis frequently occurs in the later stages of breast, lung, and several other cancers. Osteoclasts, the only cells that resorb bone, are hijacked by tumor cells, which break down bone remodeling systems. As a result, osteolysis occurs...

Cite
Kagiya T. MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. J Clin Med. 2015;4(9):1741-52doi: 10.3390/jcm4091741.
Kagiya, T. (2015). MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. Journal of clinical medicine, 4(9), 1741-52. https://doi.org/10.3390/jcm4091741
Kagiya, Tadayoshi. "MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation." Journal of clinical medicine vol. 4,9 (2015): 1741-52. doi: https://doi.org/10.3390/jcm4091741
Kagiya T. MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. J Clin Med. 2015 Aug 28;4(9):1741-52. doi: 10.3390/jcm4091741. PMID: 26343739; PMCID: PMC4600156.
Copy Download .nbib Format: NLM
Status Epilepticus: Epidemiology and Public Health Needs.

Journal of clinical medicine

Sánchez S, Rincon F.
PMID: 27537921
J Clin Med. 2016 Aug 16;5(8). doi: 10.3390/jcm5080071.

Status epilepticus (SE) is defined as a continuous clinical and/or electrographic seizure activity lasting five minutes or more or recurrent seizure activity without return to baseline. There is a paucity of epidemiological studies of SE, as most research is...

Cite
Sánchez S, Rincon F. Status Epilepticus: Epidemiology and Public Health Needs. J Clin Med. 2016;5(8)doi: 10.3390/jcm5080071.
Sánchez, S., & Rincon, F. (2016). Status Epilepticus: Epidemiology and Public Health Needs. Journal of clinical medicine, 5(8), . https://doi.org/10.3390/jcm5080071
Sánchez, Sebastián, and Rincon, Fred. "Status Epilepticus: Epidemiology and Public Health Needs." Journal of clinical medicine vol. 5,8 (2016). doi: https://doi.org/10.3390/jcm5080071
Sánchez S, Rincon F. Status Epilepticus: Epidemiology and Public Health Needs. J Clin Med. 2016 Aug 16;5(8). doi: 10.3390/jcm5080071. PMID: 27537921; PMCID: PMC4999791.
Copy Download .nbib Format: NLM
The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study.

Journal of clinical medicine research

Kakuda H, Kobayashi J, Sakurai M, Kakuda M, Takekoshi N.
PMID: 28392860
J Clin Med Res. 2017 May;9(5):403-409. doi: 10.14740/jocmr2806w. Epub 2017 Apr 01.

BACKGROUND: Postprandial hyperglycemia and hyperlipidemia are highly related to the development of atherosclerosis. Sodium/glucose cotransporter-2 (SGLT2) inhibitors have attracted attention as a new class of anti-diabetic agents for the treatment of type 2 diabetes. We investigated the effect of...

Cite
Kakuda H, Kobayashi J, Sakurai M, et al. The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study. J Clin Med Res. 2017;9(5):403-409doi: 10.14740/jocmr2806w.
Kakuda, H., Kobayashi, J., Sakurai, M., Kakuda, M., & Takekoshi, N. (2017). The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study. Journal of clinical medicine research, 9(5), 403-409. https://doi.org/10.14740/jocmr2806w
Kakuda, Hirokazu, et al. "The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study." Journal of clinical medicine research vol. 9,5 (2017): 403-409. doi: https://doi.org/10.14740/jocmr2806w
Kakuda H, Kobayashi J, Sakurai M, Kakuda M, Takekoshi N. The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study. J Clin Med Res. 2017 May;9(5):403-409. doi: 10.14740/jocmr2806w. Epub 2017 Apr 01. PMID: 28392860; PMCID: PMC5380173.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16092 entries